Search research articles
Contact Us
Filters
Showing results (31-40 of 64) with videos related to
Page
of 7
Sort By:
The Journal of Biological Chemistry
|
August 28, 1999
Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains
S W Hall, M Nagashima, L Zhao, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1983
Clinical pharmacology of the anticancer polypeptide neocarzinostatin
S W Hall, J Knight, A Broughton, et al.
Archives of Biochemistry and Biophysics
|
February 1, 1992
Binding of transforming growth factor-beta 1 to immobilized human alpha 2-macroglobulin
D J Webb, K P Crookston, S W Hall, et al.
Journal of Neurosurgery
|
August 1, 1990
Secretion of alpha 2-macroglobulin, alpha 2-antiplasmin, and plasminogen activator inhibitor-1 by glioblastoma multiforme in primary organ culture
M E Keohane, S W Hall, S R VandenBerg, et al.
American Journal of Ophthalmology
|
June 1, 1971
Microbial contamination in ocular cosmetics
L A Wilson, J W Kuehne, S W Hall, et al.
Biochemistry
|
October 31, 2001
Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib
R De Cristofaro, E De Candia, R Landolfi, et al.
Cancer Research
|
November 1, 1978
Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans
J A Benvenuto, K Lu, S W Hall, et al.
The Biochemical Journal
|
January 15, 1992
Binding of transforming growth factor-beta 1 to methylamine-modified alpha 2-macroglobulin and to binary and ternary alpha 2-macroglobulin-proteinase complexes
S W Hall, J LaMarre, L B Marshall, et al.
Cancer
|
December 1, 1979
Adriamycin, BCNU, ftorafur chemotherapy of pancreatic and biliary tract cancer
S W Hall, R S Benjamin, W K Murphy, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Bleomycin clinical pharmacology by radioimmunoassay
S W Hall, J E Strong, A Broughton, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 64) with videos related to
Sort By:
Page
of 7
The Journal of Biological Chemistry
|
August 28, 1999
Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains
S W Hall, M Nagashima, L Zhao, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1983
Clinical pharmacology of the anticancer polypeptide neocarzinostatin
S W Hall, J Knight, A Broughton, et al.
Archives of Biochemistry and Biophysics
|
February 1, 1992
Binding of transforming growth factor-beta 1 to immobilized human alpha 2-macroglobulin
D J Webb, K P Crookston, S W Hall, et al.
Journal of Neurosurgery
|
August 1, 1990
Secretion of alpha 2-macroglobulin, alpha 2-antiplasmin, and plasminogen activator inhibitor-1 by glioblastoma multiforme in primary organ culture
M E Keohane, S W Hall, S R VandenBerg, et al.
American Journal of Ophthalmology
|
June 1, 1971
Microbial contamination in ocular cosmetics
L A Wilson, J W Kuehne, S W Hall, et al.
Biochemistry
|
October 31, 2001
Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib
R De Cristofaro, E De Candia, R Landolfi, et al.
Cancer Research
|
November 1, 1978
Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans
J A Benvenuto, K Lu, S W Hall, et al.
The Biochemical Journal
|
January 15, 1992
Binding of transforming growth factor-beta 1 to methylamine-modified alpha 2-macroglobulin and to binary and ternary alpha 2-macroglobulin-proteinase complexes
S W Hall, J LaMarre, L B Marshall, et al.
Cancer
|
December 1, 1979
Adriamycin, BCNU, ftorafur chemotherapy of pancreatic and biliary tract cancer
S W Hall, R S Benjamin, W K Murphy, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Bleomycin clinical pharmacology by radioimmunoassay
S W Hall, J E Strong, A Broughton, et al.
Page
of 7